期刊文献+

雷贝拉唑、左氧氟沙星联合呋喃唑酮根除幽门螺杆菌感染 被引量:3

Efficacy and safety of rabeprazole combined with levofloxacin and furazolidone in eradication of helicobacter pylori infection
下载PDF
导出
摘要 目的探讨雷贝拉唑、左氧氟沙星联合呋喃唑酮三联方案根除幽门螺杆菌(HP)的疗效及安全性。方法选择158例符合条件的HP阳性慢性胃炎和消化性溃疡患者,随机分为2组:治疗组采用雷贝拉唑(10 mg,2次/d)、左氧氟沙星(200 mg,2次/d)联合呋喃唑酮(100 mg,2次/d),治疗7 d;之后溃疡患者继续服用雷贝拉唑10 mg,1次/d,共3周;对照组采用雷贝拉唑(10 mg,2次/d)、阿莫西林(1 000 mg,2次/d)联合克拉霉素(500 mg,2次/d),治疗7d;之后溃疡患者维持治疗同治疗组;疗程结束4周后复查,观察症状缓解率、溃疡愈合率、HP根除率及不良反应等。结果治疗组和对照组症状缓解率、溃疡愈合率及不良反应分别为91.9%(68/74)、89.7%(35/39)、8.1%(6/74)和90.1%(64/71)、88.1%(37/42)、7.0%(5/71),2组比较差异无统计学意义(P>0.05)。治疗组与对照组HP根除率分别为90.5%(67/74)、71.8%(51/71),治疗组明显高于对照组(P<0.01)。结论雷贝拉唑、左氧氟沙星联合呋喃唑酮三联方案根除幽门螺杆菌具有疗效好、不良反应少等特点,可作为根除幽门螺杆菌的治疗方案之一。 Objective To investigate the efficacy and safety of rabeprazole combined with levofloxacin and furazolidone in eradication of helicobacter pylori (Hp) itffection. Methods 158 patients with chronic gastritis or peptic ulcer with Hp infec- tion were divided into two groups at random. The treatment group was treated by rabeprazole (10mg,bid) combined with levo- floxacin ( 200rag, bid) and furazolidone ( 100mg, bid) for 7 days. The patients with peptic ulcer were given rabeprazole ( 10rag, qd) for 3 wks after the 7th day. The control group was given rabeprazole (10mg,bid) combined with amoxicillin ( 1000rag, bid) and clarithromyein(500mg,bid) for 7 days. The patients with peptic ulcer were administered the same as the treatment group after the 7th day. Tile symptomatic relief rate, ulcer concrescence rate, eradication rate of Hp and adverse reactions were recorded 4 weeks after the treatment course terminated. Results The symptomatic relief rate,ulcer concrescence rate and ad- verse reactions of the treatment group and control group were 91.9% ( 68/74), 89.7% ( 35/39 ), 8.1% ( 6/74 ) and 90.1% (64/71), 88. 1% (37/42), 7.0% (5/71) respectively. There wasn't significant difference between the two groups (P 〉 0. 05 ). However, the eradication rate was 90.5% (67/74) and 71.8% ( 51/71 ) respectively. The treatment group was higher than the control group ( P 〈 0.01 ). Conclusion Rabeprazole combined with levofloxacin and furazolidon triple therapy for Hp infection is effective and has smaller adverse effect. It is worth to be recommended as one of the treatments 'for Hp infection.
出处 《淮海医药》 CAS 2012年第1期14-15,共2页 Journal of Huaihai Medicine
关键词 螺杆菌 幽门 雷贝拉唑 左氧氟沙星 呋喃唑酮 药物疗法 联合 Helicobacter, pylori Rabeprazole Levofloxacin Furazolidone Drug therapy, combination
  • 相关文献

参考文献6

二级参考文献22

  • 1黄跃,许鲁宁.环丙沙星一周疗法根除幽门螺杆菌[J].中国新药杂志,1994,3(2):34-36. 被引量:10
  • 2中国慢性胃炎共识意见[J].胃肠病学,2006,11(11):674-684. 被引量:834
  • 3Van der Hulst RWM, Keller JJ, Rauws EAJ, et al. Theatment of Helicobacter pylori infection: a review of the world literature. Helicobacter, 1996,1:6-19.
  • 4Georgopoulos SD, Ladas SD, Karatapanis S, et al. Factors that may affect treatment outcome of triple Helicobacter pylori eradication therapy with omeprazole, amoxicillin, and clarithromycin. Dig Dis Sci,2000 ,45:63-67.
  • 5Piccolomini R, Bonaventura G, Catamo G, et al. Comparative evaluation of the E test, agar dilution, and broth microdilution for testing susceptibilities of Helicobacter pylori strains to 20 antimicrobial agents. J Clin Microbiol,1997,35:1842-1844.
  • 6Pfaller MA, Barry AL, Fuchs PC, et al. Levofloxacin disk potency and tentative interpretive criteria for susceptibility tests. J Clin Microbiol,1993, 31:1924-1926.
  • 7Sharma VK, Vasudeva R, Howden CW. A national survey of gastroenterologists' current opinions and practices related to Hp. Am J Gastroenterol,1998,93:1647-1657.
  • 8Franzin L, Pennazio M, Cabodi D, et al. Clarithromycin and amoxicillin susceptibility of Helicobacter pylori strains isolated from adult patients with gastric or duodenal ulcer in Italy. Curr Microbiol, 2000,40:96-100.
  • 9Ducons JA, Santolaria S, Guirao R, et al. Impact of clarithromycin resistance on the effectiveness of a regimen for Helicobacter pylori: a porospective study of 1-week lansoprazole, amoxycillin and clarithromycin in active peptic ulcer. Aliment Pharmacol Ther, 1999,13:775-780.
  • 10Yakoob J, Fan XG, Hu GL, et al. Antibiotic susceptibility of Helicobacter pylori in the chinese population. J Gastroenterol Hepatol, 2001,16:981-985.

共引文献205

同被引文献8

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部